Difficulty: Medium
Average Score: 85%
Practice
A student nurse is learning about prenatal testing for fetal genetic disorders and neural tube defects. What prenatal tests are screening tests in the second trimester? Select all that apply.
Correct answer
B
Rationale
In the context of prenatal testing for fetal genetic disorders and neural tube defects, selecting the correct screening tests in the second trimester is crucial for accurate assessment. The correct answer, option B - multiple marker screening, is an appropriate choice for this stage of pregnancy. Multiple marker screening, also known as quad screen or quadruple marker test, is typically performed between 15 to 20 weeks of gestation. This test evaluates maternal blood levels of various markers, such as alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol, and inhibin A. Abnormal levels of these markers can indicate an increased risk of certain genetic disorders or neural tube defects in the fetus.
In contrast, options A, C, and D are not typically performed as screening tests in the second trimester. Amniocentesis (option A) and chorionic villus sampling (CVS - option D) are diagnostic tests that involve sampling of amniotic fluid or placental tissue respectively, and are usually performed in the second trimester for definitive genetic testing if an abnormality is detected on a screening test. Cell-free DNA testing (option C) is a non-invasive prenatal test that analyzes fetal DNA circulating in the maternal bloodstream. While it can be performed in the second trimester, it is not typically considered a screening test for fetal genetic disorders and neural tube defects during this specific stage of pregnancy.
Educationally, understanding the timing and purpose of different prenatal tests is crucial for healthcare professionals involved in prenatal care. By knowing which tests are appropriate for screening in each trimester, nurses and other healthcare providers can effectively educate and support expectant parents in making informed decisions about their prenatal testing options. This knowledge also enables healthcare professionals to interpret test results accurately and provide appropriate counseling and guidance based on the findings.
In contrast, options A, C, and D are not typically performed as screening tests in the second trimester. Amniocentesis (option A) and chorionic villus sampling (CVS - option D) are diagnostic tests that involve sampling of amniotic fluid or placental tissue respectively, and are usually performed in the second trimester for definitive genetic testing if an abnormality is detected on a screening test. Cell-free DNA testing (option C) is a non-invasive prenatal test that analyzes fetal DNA circulating in the maternal bloodstream. While it can be performed in the second trimester, it is not typically considered a screening test for fetal genetic disorders and neural tube defects during this specific stage of pregnancy.
Educationally, understanding the timing and purpose of different prenatal tests is crucial for healthcare professionals involved in prenatal care. By knowing which tests are appropriate for screening in each trimester, nurses and other healthcare providers can effectively educate and support expectant parents in making informed decisions about their prenatal testing options. This knowledge also enables healthcare professionals to interpret test results accurately and provide appropriate counseling and guidance based on the findings.